A. Novak

发表

Synthesis of pyrazolo[1,2-a]pyrazole-based peptide mimetics

Uroš Grošelj, S. Gobec, M. Hrast, 2013 .

Fructose-induced metabolic syndrome decreases protein expression and activity of intestinal P-glycoprotein.

A. Novak, C. Ghanem, Yanina Cynthia Godoy, 2015, Nutrition.

Acetaminophen-induced stimulation of MDR1 expression and activity in rat intestine and in LS 174T human intestinal cell line.

A. G. Blazquez, A. Novak, S. Villanueva, 2011, Biochemical pharmacology.

A Simple Synthesis of Polyfunctionalized 4‐Aminopyrazolidin‐3‐ones as ‘Aza‐deoxa’ Analogs of D‐Cycloserine

Uroš Grošelj, S. Gobec, M. Hrast, 2014 .

Regio- and stereoselective cycloadditions of (1Z,4R∗,5R∗)-1-arylmethylidene-4-benzoylamino-3-oxo-5-phenylpyrazolidin-1-ium-2-ides to methyl methacrylate

Uroš Grošelj, A. Novak, Jure Bezenšek, 2011 .

Chemical ionization mass spectrometry utilizing ammonium ions (NH4+ CIMS) for measurements of organic compounds in the atmosphere

J. Crounse, P. Wennberg, J. Neuman, 2022, Atmospheric Measurement Techniques.

Properties of partially purified goat kidney β-D-mannosidase

J. Callahan, A. Novak, J. Clarke, 1990 .

One-pot parallel solution-phase synthesis of 1-substituted 4-(2-aminoethyl)-1H-pyrazol-5-ols.

A. Meden, Uroš Grošelj, A. Novak, 2008, Journal of combinatorial chemistry.

Parallel Synthesis of 1-Substituted5-(5-Oxopyrrolidin-3-yl)-1H-pyrazole-4-carboxamides

D. Kočar, Uroš Grošelj, A. Novak, 2011 .

Acetaminophen inhibits intestinal p-glycoprotein transport activity.

A. Novak, A. Mottino, C. Ghanem, 2013, Journal of pharmaceutical sciences.

An efficient site-selective, dual bioconjugation approach exploiting N-terminal cysteines as minimalistic handles to engineer tailored anti-HER2 affibody conjugates.

V. Aucagne, A. Novak, S. Morisset-Lopez, 2023, European journal of medicinal chemistry.

Serendipity at work: unexpected ring transformations of 4 aminopyrazolidin-3-ones into N-aminohydantoins

Uroš Grošelj, A. Novak, Jure Bezenšek, 2010 .